The new facility expands the footprint of manufacturing, research, and development for ifm process instruments in the United States to 90,000 square feet. MALVERN, PENNSYLVANIA / ACCESS Newswire / ...
Novartis is to buy US biotech IFM Tre in a deal worth up to $1.575 billion, adding a potential drug for the fatty liver disease known as NASH to its pipeline. IFM Tre is a subsidiary of cancer biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results